Stay updated on Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe history now includes Revision: v3.5.0 and no longer lists Revision: v3.4.3.SummaryDifference0.1%

- Check16 days agoChange DetectedRecord History shows termination of the study and posting of results, with updated status entries (Results Posted) and related changes. The prior 'Completed' and 'Results Submitted' status entries were removed.SummaryDifference0.5%

- Check23 days agoChange DetectedA new revision v3.4.3 was added to the history, and revision v3.4.2 was removed.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded results-related sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and QC/status notes in the latest version. This expands access to core study data and documentation.SummaryDifference0.8%

- Check51 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the prior Notice about government funding/operating status and Revision: v3.4.1.SummaryDifference0.5%

- Check58 days agoChange DetectedThe history now includes 'Results Submitted' and a new 'Revision: v3.4.1', replacing the previous 'No Results Posted' and 'Revision: v3.4.0'. A site-wide notice about government funding and NIH operations has also been added.SummaryDifference0.5%

Stay in the know with updates to Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.